173 related articles for article (PubMed ID: 17483472)
61. Molecular mechanisms governing microRNA-125a expression in human hepatocellular carcinoma cells.
Potenza N; Panella M; Castiello F; Mosca N; Amendola E; Russo A
Sci Rep; 2017 Sep; 7(1):10712. PubMed ID: 28878257
[TBL] [Abstract][Full Text] [Related]
62. 11q deletion in neuroblastoma: a review of biological and clinical implications.
Mlakar V; Jurkovic Mlakar S; Lopez G; Maris JM; Ansari M; Gumy-Pause F
Mol Cancer; 2017 Jun; 16(1):114. PubMed ID: 28662712
[TBL] [Abstract][Full Text] [Related]
63. Notch/Hes signaling and miR-9 engage in complex feedback interactions controlling neural progenitor cell proliferation and differentiation.
Roese-Koerner B; Stappert L; Brüstle O
Neurogenesis (Austin); 2017; 4(1):e1313647. PubMed ID: 28573150
[TBL] [Abstract][Full Text] [Related]
64. Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
Coppola N; de Stefano G; Panella M; Onorato L; Iodice V; Minichini C; Mosca N; Desiato L; Farella N; Starace M; Liorre G; Potenza N; Sagnelli E; Russo A
Oncotarget; 2017 Apr; 8(15):25289-25299. PubMed ID: 28445974
[TBL] [Abstract][Full Text] [Related]
65. LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration.
Xiong D; Sheng Y; Ding S; Chen J; Tan X; Zeng T; Qin D; Zhu L; Huang A; Tang H
Oncotarget; 2016 Jul; 7(30):47593-47608. PubMed ID: 27351280
[TBL] [Abstract][Full Text] [Related]
66. MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
Lee M; Kim EJ; Jeon MJ
Oncotarget; 2016 Feb; 7(8):8726-42. PubMed ID: 26646586
[TBL] [Abstract][Full Text] [Related]
67. Identification of linc-NeD125, a novel long non coding RNA that hosts miR-125b-1 and negatively controls proliferation of human neuroblastoma cells.
Bevilacqua V; Gioia U; Di Carlo V; Tortorelli AF; Colombo T; Bozzoni I; Laneve P; Caffarelli E
RNA Biol; 2015; 12(12):1323-37. PubMed ID: 26480000
[TBL] [Abstract][Full Text] [Related]
68. Chemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastoma.
Buhagiar A; Ayers D
Anal Cell Pathol (Amst); 2015; 2015():150634. PubMed ID: 26258008
[TBL] [Abstract][Full Text] [Related]
69. MiR-125a-3p regulates glioma apoptosis and invasion by regulating Nrg1.
Yin F; Zhang JN; Wang SW; Zhou CH; Zhao MM; Fan WH; Fan M; Liu S
PLoS One; 2015; 10(1):e0116759. PubMed ID: 25560389
[TBL] [Abstract][Full Text] [Related]
70. Regulatory networks between neurotrophins and miRNAs in brain diseases and cancers.
Shi J
Acta Pharmacol Sin; 2015 Feb; 36(2):149-57. PubMed ID: 25544363
[TBL] [Abstract][Full Text] [Related]
71. TrkC expression predicts favorable clinical outcome in invasive ductal carcinoma of breast independent of NT-3 expression.
Zhang W; Lin ZC; Zhang TX; Liu S; Liu X; Liu JJ; Niu Y
Am J Cancer Res; 2014; 4(6):811-23. PubMed ID: 25520870
[TBL] [Abstract][Full Text] [Related]
72. Significance and therapeutic value of miRNAs in embryonal neural tumors.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Molecules; 2014 May; 19(5):5821-62. PubMed ID: 24806581
[TBL] [Abstract][Full Text] [Related]
73. MicroRNAs in neuroblastoma: small-sized players with a large impact.
Zhi F; Wang R; Wang Q; Xue L; Deng D; Wang S; Yang Y
Neurochem Res; 2014 Apr; 39(4):613-23. PubMed ID: 24477657
[TBL] [Abstract][Full Text] [Related]
74. Epigenetics, nervous system tumors, and cancer stem cells.
Qureshi IA; Mehler MF
Cancers (Basel); 2011 Sep; 3(3):3525-56. PubMed ID: 24212967
[TBL] [Abstract][Full Text] [Related]
75. miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.
Ferracin M; Bassi C; Pedriali M; Pagotto S; D'Abundo L; Zagatti B; Corrà F; Musa G; Callegari E; Lupini L; Volpato S; Querzoli P; Negrini M
Mol Cancer; 2013 Oct; 12(1):130. PubMed ID: 24165569
[TBL] [Abstract][Full Text] [Related]
76. TDP-43 regulates the microprocessor complex activity during in vitro neuronal differentiation.
Di Carlo V; Grossi E; Laneve P; Morlando M; Dini Modigliani S; Ballarino M; Bozzoni I; Caffarelli E
Mol Neurobiol; 2013 Dec; 48(3):952-63. PubMed ID: 24113842
[TBL] [Abstract][Full Text] [Related]
77. Biogenesis, evolution and functional targets of microRNA-125a.
Potenza N; Russo A
Mol Genet Genomics; 2013 Sep; 288(9):381-9. PubMed ID: 23783428
[TBL] [Abstract][Full Text] [Related]
78. Epigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectives.
Romania P; Bertaina A; Bracaglia G; Locatelli F; Fruci D; Rota R
Int J Mol Sci; 2012 Dec; 13(12):16554-79. PubMed ID: 23443118
[TBL] [Abstract][Full Text] [Related]
79. The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.
Domingo-Fernandez R; Watters K; Piskareva O; Stallings RL; Bray I
Pediatr Surg Int; 2013 Feb; 29(2):101-19. PubMed ID: 23274701
[TBL] [Abstract][Full Text] [Related]
80. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment.
Morlando M; Dini Modigliani S; Torrelli G; Rosa A; Di Carlo V; Caffarelli E; Bozzoni I
EMBO J; 2012 Dec; 31(24):4502-10. PubMed ID: 23232809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
